Thrombolysis in central retinal artery occlusion: a retrospective observational study.
Florian Philipp RaberFlorian Vincent GmeinerJens DreyhauptArmin WolfAlbert Christian LudolphJens Ulrich WernerJan KassubekKatharina AlthausPublished in: Journal of neurology (2022)
Early intravenous thrombolysis therapy according to the current stroke protocol n a time window up to 4.5 h after the onset of symptoms was feasible and might be a potential treatment option for NA-CRAO. Patients with NA-CRAO are at very high risk of ischemic stroke and MRI should be done in all patients for optimized treatment and secondary stroke prevention. A prospective randomized study is required.
Keyphrases
- atrial fibrillation
- end stage renal disease
- pulmonary embolism
- randomized controlled trial
- magnetic resonance imaging
- ejection fraction
- chronic kidney disease
- acute ischemic stroke
- newly diagnosed
- stem cells
- peritoneal dialysis
- computed tomography
- depressive symptoms
- diabetic retinopathy
- high dose
- contrast enhanced
- mesenchymal stem cells
- bone marrow
- magnetic resonance
- replacement therapy
- diffusion weighted imaging
- cell therapy
- human health